IRTC · XBRL financial data

iRhythm Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (IRTC's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers125133*132148148164*159187193209*199224
Cost of revenue4245*44454649*49545661*5861
Gross profit8287*88103101115*109133137148*141163
Research and development1615*1720————————
Selling, general and administrative94100*109107103100*120126124122*136132
Total operating expenses110127*126126152119*142152146146*158166
Operating income (loss)(28)(39)*(38)(23)(50)(4)*(33)(19)(8)2*(16)(3)
Interest income22*3766*5565*55
Interest expense11*3333*3333*33
Other income (expense)(0)6*3610*1212*11
Income tax expense (benefit)00*0000*1(0)00*10
Net income (loss)(27)(39)*(46)(20)(46)(1)*(31)(14)(5)6*(14)(0)
Earnings per share, basic USD per share(0.89)(1.26)*(1.47)(0.65)(1.48)(0.04)*(0.97)(0.44)(0.16)0.17*(0.43)(0.01)
Earnings per share, diluted USD per share(0.89)(1.26)*(1.47)(0.65)(1.48)(0.04)*(0.97)(0.44)(0.16)0.17*(0.43)(0.01)
Weighted average shares, basic millions of shares3131*31313131*32323232*3333
Weighted average shares, diluted millions of shares3131*31313131*32323232*3333

Balance sheet

CSV

Fiscal quarters (IRTC's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents4736520551520420375309256236240247
Marketable securities1119849112116145236310348309345
Accounts receivable506190867780818276768184
Inventory141415151514141820222423
Prepaid and other current assets122214151316201819222658
Total current assets234231687678628646636664680703681756
Property and equipment, net97104112118122125131140149152157165
Right-of-use asset614948474648464543424039
Goodwill111111111111
Total assets4404339109199109319269649951,0201,0061,093
Accounts payable7681387121382917
Accrued liabilities77837066748580100118129102158
Total current liabilities1021079798100111111132147152132196
Long-term debt3535——————————
Lease liability, non-current828078767475727068656259
Total liabilities220223819820838841839860873867845907
Accumulated deficit(607)(646)(691)(711)(758)(759)(790)(804)(809)(803)(817)(818)
Total stockholders' equity2202109099729187104122153161186
Total liabilities and equity4404339109199109319269649951,0201,0061,093
Common shares outstanding (cover page) millions of shares313131313131323232323333

Cash flows

CSV

Fiscal quarters (IRTC's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(27)(39)*(46)(20)(46)(1)*(31)(14)(5)6*(14)(0)
Stock-based compensation21*24*2122*17*16*2323*21*21*2120*
Depreciation and amortization45*5555*5555*55
Net cash from operating activities1*(16)*(52)12*24*19*(8)28*35*26*(26)51*
Purchases of property and equipment9*14*108*9*7*910*15*12*714*
Net cash from investing activities(15)*1*4015*(55)*(122)*(38)(101)*(89)*(49)*30(49)*
Share repurchases0*0*250*0*0*00*0*0*——
Repayments of long-term debt0*0*——————————
Net cash from financing activities0*3*5054*(0)*3*27*1*3*04*
Net change in cash(14)*(11)*49330*(31)*(100)*(44)(66)*(54)*(20)*47*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
iRhythm Holdings24722451*33.0M 10-QJun 30, 2026
Merit Medical Systems50441665*59.9M 10-QSep 30, 2026
TransMedics Group49119017*34.7M 10-QJun 30, 2026
Integer Holdings1445037*34.0M 10-QOct 2, 2026
GLAUKOS16221139*59.2M 10-QSep 30, 2026
Masimo1254044552.4M 10-QApr 4, 2026
Inspire Medical Systems19120746*29.0M 10-QSep 30, 2026
MSA Safety18753682*38.5M 10-QSep 30, 2026
Globus Medical508790210*134.3M 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.